Natus Executives to Present at Upcoming Financial Conferences

Share
SAN CARLOS, Calif.--(BUSINESS WIRE)--

Natus Medical Incorporated (Nasdaq: BABY) today announced that executives of the Company are scheduled to speak at two upcoming financial conferences.

Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will make a presentation at the Raymond James 31st Annual Institutional Investors Conference. The conference is being held at the JW Marriott Grande Lakes Resort located at 4040 Central Florida Parkway, Orlando, Florida on March 7-10, 2010. Mr. Murphy is scheduled to present on Monday, March 8 at 10:25 a.m. Eastern Time (7:25 a.m. PT). Attendance at the Raymond James 31st Annual Institutional Investors Conference is by invitation only.

Jim Hawkins, President and Chief Executive Officer of the Company, will make a presentation at the Cowen & Company 30th Annual Healthcare Conference. The conference is being held at The Boston Marriott Copley Place located at 110 Huntington Avenue, Boston, Massachusetts on March 8-11, 2010. Mr. Hawkins is scheduled to present on Monday, March 8 at 1:00 p.m. Eastern Time (10:00 a.m. PT). Attendance at the Cowen & Company 30th Annual Healthcare Conference is by invitation only.

Investors may listen to the live webcasts and view a copy of the slide presentations online via the “Investors” section of the Company’s web site at http://investor.natus.com. The recorded webcasts will be accessible online for at least 30 days.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Brienne H. Fisher, 650-802-0400
Director of Investor Relations
InvestorRelations@Natus.com



 
 
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance